Skip to main content
Caplight Logo









Freya Ophthalmics

Freya Ophthalmics

Private
Jacksonville, FloridaHealthcare & Life Scienceshttps://freyaophthalmics.com/

Last Round

Series A

Oct 29, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Freya Ophthalmics is a biotech company that develops a drug-eluting contact lens platform for the treatment of ocular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

drug-eluting contact lenstherapeutic contact lensmedicated contact lensocular drug deliveryophthalmologysustained drug deliveryeye drops alternativeclinical-stage biotechglaucoma treatmentmyopia controlocular cystinosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Freya Ophthalmics Comparables

Compare Freya Ophthalmics with similar companies based on industry and business-model similarity.

Freya Ophthalmics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OcuMedic, Inc.
93%
MediPrint Ophthalmics
88%
Mati Therapeutics
80%

Freya Ophthalmics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 29, 2025

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2025

    $14.25M round completed.

Freya Ophthalmics Filings

Explore SEC and related filing metadata, where available.

Freya Ophthalmics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Freya Ophthalmics's valuation, stock price, and market status.

Is Freya Ophthalmics a public or private company?

Freya Ophthalmics is a private company.

What is the current stock price of Freya Ophthalmics?

Freya Ophthalmics is a private company with no public stock price. No recent secondary market data is available.

How much is Freya Ophthalmics worth (valuation)?

Valuation information for Freya Ophthalmics is not publicly available.

Can I buy Freya Ophthalmics stock?

Freya Ophthalmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Freya Ophthalmics's last funding round?

Funding round information for Freya Ophthalmics is not publicly available.

Who are the main investors in Freya Ophthalmics?

Investor information for Freya Ophthalmics is not publicly disclosed.

Will Freya Ophthalmics IPO soon?

No public IPO plans have been announced for Freya Ophthalmics.

How can I track Freya Ophthalmics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Freya Ophthalmics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJacksonville, Florida
Year FoundedN/A
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?